Department of Orthopaedics: Moderators

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 31

DEPARTMENT OF

ORTHOPAEDICS
KMC,MANGLORE

DR.VINAY PAWAR

MODERATORS
DR.SURENDAR U. KAMATH
DR.HARSHVARDHAN

MADURA
FOOT

WHY WE SHOULD KNOW?


1.CAN BE CONFUSED WITH CHRONIC
OSTEOMYELITIS
2.CAN ITSELF CAUSE BONE INFECTION
3.ENDEMIC IN INDIA( ESPECIALLY
TAMIL NADU)

History

There have been


references of this
disease in Homers
Iliad
The clinical syndrome
was first described by
Gill-1842 in
Madurai,TN
Its fungal etiology
was established by
Carter-1868

Definition.

it is a chronic,painless,subcutaneous,
infection usually involving the feet,
characterized by formation of
localised leasions in form of
tumefactions and multiple draining
sinuses

Etiology..

Madura Foot- Actinomycosis


Mycetoma1.Bacterial
2.Fungal
3.S.Aureus- Botryomycosis

MYCETOMA

BACTERIAL
1.ACTINOMYCETES-A.Israelis,A.Bovis
2.NOCARDIA-N.Asteroides,N.Brazilienses
3.ACTINOMADURA-A.madurae,A.pelletreinie
4.STREPTOMYCES-S.somalienses

FUNGAL
1.Petrielldium Boydii
2.Madurella mycetomi
3.Acremonium spp
.

MODE OF INFECTION

CAN OCCUR ANYWHERE

The body parts affected.

most commonly -foot or lower leg.


The hand is the next most common
location.
The causative organism enters through
sites of local trauma (eg, cut on the hand,
foot splinter, local trauma related to
carrying soil-contaminated material).
Walking with bare feet

Clinical History

The earliest symp-painless subcutaneous


swelling..

Several years later- painless subcutaneous


nodule

After some years, massive swelling of the


area occurs, with induration, skin rupture,
and sinus tract formation.

Pain-secondary bacterial infection less


commonly, bone invasion.

Constitutional symptoms and signs are rare.

STAINING

H/E staining/Geimsa for detection of grains.


Actinomycetoma - Homogenously
eosinophilic
Eumycetoma - Brownish
The causal agent of each type of mycetoma
can be visualized better with the following:
Tissue Gram stain to detect fine, grampositive, branching filaments within the
actinomycetoma grain
Gomori methenamine silver or periodic acidSchiff stain to demonstrate the larger
hyphae of eumycetoma

White-to-yellow grains P boydii (S


apiospermum), Nocardia species, or A
madurae infection.
Yellow-to-brown grains S somaliensis
infection.
Black grains Streptomyces
paraguayensis, Madurella species, or
Leptosphaeria species infection.
Red-to-pink grains A pelletieri .

Culture
Lwenstein-Jensen actinomycetoma
blood agar for eumycetoma.
Serologic diagnosis
(1) immunodiffusion,
(2) counterimmunoelectrophoresis,
(3) enzyme-linked immunosorbent assay, or
(4) Western blot.

IMAGING STUDIES
Cortical

thinning
sunray appearance and a Codman
triangle.
Multiple lytic lesions large, few in
number, and with well-defined
margins in eumycetoma
small, numerous, and with ill-defined
margins in actinomycetoma.
Disuse osteoporosis may occur in late
mycetoma.

Radiological staging

Stage 0 - Soft-tissue swelling without bone


involvement
Stage I - Extrinsic pressure effects on the intact bones
in the vicinity of an expanding granuloma
Stage II - Irritation of the bone surface without
intraosseous invasion
Stage III - Cortical erosion and central cavitation
Stage IV - Longitudinal spreading along a single row
Stage V - Horizontal spread along a single row
Stage VI - Multidirectional spread due to uncontrolled
infection

MRI D/D of the swelling and degree of bone and


soft tissue involvement.
-dot in circle sign: 2.5mm signals of high
intensity signals in low intensity foci-highly specific
for mycetoma
USG- Single or multiple thick-walled cavities with
hyperreflective echoes and no acoustic
enhancement always are observed with
mycetoma, whereas these features are not
demonstrated in nonmycetoma swellings.
eumycetoma, echoes are sharp,
actinomycetoma, echoes are fine and aggregated
and commonly settle at the provides a better
bottom of the cavities.
CT scan detail of changes than x-ray

Treatment..

Medical Care: Antibiotic or


antifungal treatment should be
attempted first and may need to be
combined with limited surgery
Surgery

ACTINOMYCETOMA

2 drugs in 5 weeks
cycle are used
Tmp/Smx-160/800mg
6thhourly PO
Amikacin-15mg/kg/d
IV/IM QID
Dapsone-10mg BD PO
-amikacin substituted by
streptomycin
-rifampicin in resistant
cases

EUMYCETOMA
-difficult to treat
-surgery is prefered for
localised leasions
-may respond partially
to Antifungals
Ketoconazole
(200mgbd)
Itraconazole (200mg
bd)
Amphotericin B
10 months

Deterrence/Prevention:
Educate patients to avoid activities that expose
them to agents of mycetoma

Complications:
Amputation may result from neglected chronic infections.
Prognosis:
Prognosis is good with prompt diagnosis and treatment.
Although prognosis for survival is good, amputations
or ankylosis can lessen the quality of life.
In late stages, response to treatment is limited .

THANK

You might also like